Does GOLD THIOMALATE Cause Mobility decreased? 818 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 818 reports of Mobility decreased have been filed in association with GOLD THIOMALATE. This represents 18.3% of all adverse event reports for GOLD THIOMALATE.
818
Reports of Mobility decreased with GOLD THIOMALATE
18.3%
of all GOLD THIOMALATE reports
480
Deaths
634
Hospitalizations
How Dangerous Is Mobility decreased From GOLD THIOMALATE?
Of the 818 reports, 480 (58.7%) resulted in death, 634 (77.5%) required hospitalization, and 444 (54.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLD THIOMALATE. However, 818 reports have been filed with the FAERS database.
What Other Side Effects Does GOLD THIOMALATE Cause?
Drug ineffective (2,904)
Rheumatoid arthritis (2,472)
Off label use (1,909)
Joint swelling (1,804)
Drug hypersensitivity (1,778)
Drug intolerance (1,681)
Pain (1,663)
Contraindicated product administered (1,583)
Treatment failure (1,530)
Arthralgia (1,481)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GOLD THIOMALATE Alternatives Have Lower Mobility decreased Risk?
GOLD THIOMALATE vs GOLIMUMAB
GOLD THIOMALATE vs GOLODIRSEN
GOLD THIOMALATE vs GONADORELIN
GOLD THIOMALATE vs GONADOTROPHIN, CHORIONIC
GOLD THIOMALATE vs GOSERELIN